arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

UFP Technologies, Inc.

UFPT Health Care Medical/Dental Instruments
$297.33
▲ +2.1% Today
as of Oct 22, 16:53 ET
Last 30 days +6.96% Sep 14 → Oct 22
$272.86 $282.11 $291.37 $300.63 $309.88 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$290.17
High
$297.72
Low
$290.17
Volume
$82,301
Avg Vol
$176,214
Mkt Cap
$2.3B
P/E (TTM)
59.28
Beta
—
52w High
$338.71
52w Low
$173.86
Div Yield
—
Shares Out
$8M

Recent Press Releases & News last 60 days · 10 items

Oct 22 · 13:41 StockStory
2 Reasons to avoid UFPT and 1 stock to buy instead
Oct 6 · 19:04 StockStory
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment
Sep 26 · 12:09 Simply Wall St.
UFP Technologies (UFPT) Stock Looks Rich Despite Its 378% Five Year Run
▸ Show all 10 press releases & news Free account →

UFPT earnings at a glance

UFP Technologies, Inc. (UFPT) is scheduled to report earnings on Monday, November 2, 2026 — in 10 days. Analysts expect earnings per share of $2.63, compared with $2.39 in the same quarter last year (+10%). The options market is pricing a move of about ±4.6% after the report, a range of roughly $283.76 to $310.90 from today's $297.33. Over its last 6 reports the stock rose the next day 5 times and fell 1, moving ±9.0% on average; after the most recent report on Aug 3, 2026 it moved +25.2%. That means options currently expect less movement than UFPT has typically delivered. UFPT beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 39%. The share price of $297.33 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$174
$339
75% of range
Avg surprise (last 6)
+12.6%
Avg reaction (last 6)
+9.0%
83% positive
Latest IV / EM
39%
EM ±4.6% · $290 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$2.05$2.27$2.48$2.70$2.92 Actual $2.47Est $2.05Actual $2.50Est $2.29Actual $2.39Est $2.22Actual $2.44Est $2.26Actual $2.48Est $2.18Actual $2.92Est $2.51 Mar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$46M$91M$137M$183M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon Aug 3, 2026Jun/2026 $2.92 $2.51 +16.3% +0.4% +25.2% earnings
Mon May 4, 2026Mar/2026 $2.48 $2.18 +13.8% +0.4% +10.3% earnings
Tue Feb 24, 20268K 2026-02-24 $2.44 $2.26 +8.0% — -0.2% earnings
Mon Nov 3, 2025Sep/2025 $2.39 $2.22 +7.7% — +12.1% earnings
Mon Aug 4, 2025Jun/2025 $2.50 $2.29 +9.2% — +6.4% earnings
Tue May 6, 2025Mar/2025 $2.47 $2.05 +20.5% — +0.1% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Nov 2, 2026Sep/2026OTHER $2.63$2.39 +10.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$174M$154M——$151M$148M——
Cost of revenue$123M$110M—$112M$108M$106M—$104M
Gross profit$51M$44M——$44M$42M——
Operating income$28M$23M—$23M$24M$23M—$25M
Net income$21M$17M——$17M$17M——
EPS (diluted)$2.68$2.24——$2.21$2.21——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$9M$20M$20M$18M$15M$14M$13M$16M
Inventory$100M$94M$87M$86M$85M$90M$88M$89M
Total current assets$235M$224M$201M$198M$191M$206M$195M$201M
Total assets$682M$675M$655M$653M$635M$643M$629M$639M
Long-term debt$105M$125M$123M$134M$151M$164M$177M$200M
Total liabilities$219M$236M$231M$249M$249M$282M$286M$309M
Total equity$462M$439M$424M$404M$385M$361M$343M$329M

Implied volatility — last 90 days

31%49%68%87%105% Jun 07 — IV 52% · EM ±7.1%Jun 08 — IV 47% · EM ±6.2%Jun 09 — IV 48% · EM ±6.1%Jun 10 — IV 48% · EM ±5.6%Jun 11 — IV 42% · EM ±4.6%Jun 12 — IV 54% · EM ±5.6%Jun 15 — IV 68% · EM ±4.9%Jun 16 — IV 73% · EM ±4.3%Jun 17 — IV 106% · EM ±4.4%Jun 19 — IV 38% · EM ±8.4%Jun 22 — IV 41% · EM ±8.6%Jun 23 — IV 40% · EM ±8.1%Jun 24 — IV 37% · EM ±7.4%Jun 25 — IV 38% · EM ±7.5%Jun 26 — IV 33% · EM ±6.3%Jun 29 — IV 36% · EM ±6.4%Jun 30 — IV 36% · EM ±6.2%Jul 01 — IV 34% · EM ±5.6%Jul 02 — IV 35% · EM ±5.6%Jul 03 — IV 36% · EM ±5.6%Jul 06 — IV 37% · EM ±5.2%Jul 07 — IV 39% · EM ±5.1%Jul 08 — IV 41% · EM ±5.2%Jul 09 — IV 41% · EM ±4.8%Jul 10 — IV 46% · EM ±5.1%Jul 13 — IV 56% · EM ±4.7%Jul 14 — IV 61% · EM ±4.4%Jul 15 — IV 97% · EM ±5.7%Jul 16 — IV 94% · EM ±3.9%Jul 20 — IV 49% · EM ±11.5%Jul 21 — IV 49% · EM ±11.5%Jul 22 — IV 49% · EM ±11.1%Jul 23 — IV 50% · EM ±11.2%Jul 24 — IV 49% · EM ±10.9%Jul 27 — IV 49% · EM ±10.3%Jul 28 — IV 49% · EM ±10.1%Jul 29 — IV 50% · EM ±9.9%Jul 30 — IV 48% · EM ±9.4%Jul 31 — IV 51% · EM ±9.8%Aug 03 — IV 49% · EM ±8.7%Aug 04 — IV 39% · EM ±6.7%Aug 05 — IV 38% · EM ±6.3%Aug 06 — IV 36% · EM ±5.8%Aug 07 — IV 35% · EM ±5.4%Aug 10 — IV 36% · EM ±5.0%Aug 11 — IV 33% · EM ±4.4%Aug 12 — IV 34% · EM ±4.2%Aug 13 — IV 31% · EM ±3.7%Aug 14 — IV 31% · EM ±3.5%Aug 17 — IV 39% · EM ±3.3%Aug 18 — IV 70% · EM ±5.1%Aug 19 — IV 57% · EM ±3.4%Aug 20 — IV 87% · EM ±3.6%Aug 24 — IV 34% · EM ±7.2%Aug 25 — IV 34% · EM ±6.9%Aug 26 — IV 34% · EM ±6.9%Aug 27 — IV 33% · EM ±6.4%Aug 28 — IV 31% · EM ±6.0%Aug 31 — IV 33% · EM ±5.8%Sep 01 — IV 34% · EM ±5.8%Sep 02 — IV 35% · EM ±5.8%Sep 03 — IV 34% · EM ±5.5%Sep 04 — IV 34% · EM ±5.4%Sep 07 — IV 39% · EM ±5.4%Sep 08 — IV 36% · EM ±4.8%Sep 09 — IV 47% · EM ±5.9%Sep 10 — IV 51% · EM ±6.0%Sep 11 — IV 47% · EM ±5.1%Sep 14 — IV 61% · EM ±5.1%Sep 15 — IV 68% · EM ±4.9%Sep 16 — IV 71% · EM ±4.2%Sep 17 — IV 97% · EM ±4.1%Sep 21 — IV 41% · EM ±8.5%Sep 22 — IV 42% · EM ±8.6%Sep 23 — IV 39% · EM ±7.8%Sep 24 — IV 39% · EM ±7.6%Sep 25 — IV 42% · EM ±8.0%Sep 28 — IV 41% · EM ±7.3%Sep 29 — IV 44% · EM ±7.5%Sep 30 — IV 41% · EM ±6.9%Oct 01 — IV 45% · EM ±7.3%Oct 02 — IV 43% · EM ±6.7%Oct 06 — IV 48% · EM ±6.3%Oct 07 — IV 44% · EM ±5.6%Oct 08 — IV 39% · EM ±4.6%

Sector peers

INSP
Inspire Medical Systems, Inc.
$2.0B $72.66+1.9%
ATRC
AtriCure, Inc.
$2.7B $59.30+2.8%
LMAT
LeMaitre Vascular, Inc.
$1.8B $85.33+2.3%
NVCR
NovoCure Limited
$1.7B $15.10-3.9%
XRAY
DENTSPLY SIRONA Inc.
$1.7B $9.50+7.1%
ATEC
Alphatec Holdings, Inc.
$1.6B $11.36+4.6%

UFPT earnings FAQ

When is UFPT's next earnings date?

UFP Technologies, Inc. is expected to report on November 2, 2026.

What is UFPT's expected move for earnings?

Options currently price a move of about ±4.6%, or $13.57 per share either way from $297.33.

How does UFPT stock usually react to earnings?

Across the last 6 reports the average next-day move was ±9.0%, up 5 times and down 1 times.

What EPS are analysts expecting from UFP Technologies, Inc.?

The consensus estimate is $2.63 per share, versus $2.39 a year ago.

What is UFPT's implied volatility?

UFPT's at-the-money implied volatility is about 39% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in